-
Mashup Score: 0
Although the annual retinopathy screening rate in patients with lupus receiving hydroxychloroquine has increased from 3.5% in 2006 to 22.5% in 2019, more work is needed to raise awareness, according to data from a South Korean study.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0(PDF) Survey on Usage of Weekly Hydroxychloroquine Prophylaxis against COVID19 amongst Healthcare Workers in India - 2 year(s) ago
PDF | We did a survey across 11 hospitals in 7 cities in India about HCQ prophylaxis amongst HCW.A total of 301 HCW reported to be taking HCQ 400 mg… | Find, read and cite all the research you need on ResearchGate
Source: ResearchGateCategories: Hem/Oncs, Latest HeadlinesTweet-
We have a come a long way in this #covid19Pandemic Way back in 2020 #HCQ was the big hope & then it went bust! We had published this- Survey on Usage of Weekly Hydroxychloroquine Prophylaxis against COVID19 amongst Healthcare Workers in India https://t.co/vYls8UPBA3
-
-
Mashup Score: 0Podcasts - 2 year(s) ago
Open Forum Infectious Diseases provides free podcast interviews with experts in the field, keeping you up to date with the latest research on your computer or on the go. Now available on Apple Podcasts or…
Source: Oxford AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
Trials were made possible by a great team, who have worked together for years on #crypto meningitis. The best podcast on our #hcq trials was by @PaulSaxMD for OFID, which overall has a lot of great podcasts on ID #IDTwitter and #Covid_19 topics. https://t.co/CJ4ZHC9uxV
-
-
Mashup Score: 19Scientific Correction Has Failed - 2 year(s) ago
How Covid-19 has exposed the cracks in the system
Source: MediumCategories: Healthcare Professionals, Latest HeadlinesTweet-
Scientific Correction Has Failed https://t.co/HuHJg0cqIQ b @GidMK #Ivermectin, #VitaminD, #HCQ. A litany of "fake research has caused massive problems during the pandemic." "This endless cavalcade of retracted papers include many that were used to support treatment decisions."
-
-
Mashup Score: 67
The official blog of the UK Health Security Agency, providing expert insight on the organisation’s work and all aspects of health security
Source: ukhsa.blog.gov.ukCategories: Healthcare Professionals, Latest HeadlinesTweet-
Revisionist spin accelerating. Reality: 1) #VaccinesWORK (STILL https://t.co/YdiM4ez2gM). 2) #MasksWork (https://t.co/mI3EuXndfu) 3) "Lockdown" strategies worked (https://t.co/xIb9Ieq0be) 4) Deaths NOT exaggerated and #Ivermectin, #HCQ, etc NOT helpful. #ScienceUpFirst https://t.co/cBsOm5tbRM
-
-
Mashup Score: 6Blog: HCQ efficacy, dosing, and retinopathy webinar | British Society for Rheumatology - 2 year(s) ago
With hydroxychloroquine (HCQ) efficacy, dosing and retinopathy being a topic of wide interest to the profession we partnered with Blackrock Pharmaceuticals to deliver an educational webinar to support members’ learning. Prof Chris Edwards, University Hospital Southampton, Dr James Galloway, King’s College London and Dr Imran…
Source: rheumatology.org.ukCategories: Latest Headlines, RheumatologyTweet-
Hear what we learnt about #HCQ dosing efficacy, retinopathy and more in our recent webinar from Prof Chris Edwards, @drjamesgalloway (pictured) and Dr Imran Yusuf ▶️ https://t.co/3qhupzNXC5 https://t.co/3x4Fia7A5q
-
-
Mashup Score: 0Blog: HCQ efficacy, dosing, and retinopathy webinar | British Society for Rheumatology - 3 year(s) ago
With hydroxychloroquine (HCQ) efficacy, dosing and retinopathy being a topic of wide interest to the profession we partnered with Blackrock Pharmaceuticals to deliver an educational webinar to support members’ learning. Prof Chris Edwards, University Hospital Southampton, Dr James Galloway, King’s College London and Dr Imran…
Source: rheumatology.org.ukCategories: Latest Headlines, RheumatologyTweet-
Hear what we learnt about #HCQ dosing efficacy, retinopathy and more in our recent webinar, from Prof Chris Edwards, @drjamesgalloway and Dr Imran Yusuf ▶️ https://t.co/3qhupzNXC5 https://t.co/dQ3u7uYTqK
-
-
Mashup Score: 0Hydroxychloroquine: efficacy, dosing and retinopathy | British Society for Rheumatology - 3 year(s) ago
A webinar to ensure rheumatologists know the llatest information around HCQ efficacy, dosing and retinopathy so they can make confident and appropriate prescribing decisions around this important agent in both rheumatoid arthritis and lupus.
Source: rheumatology.org.ukCategories: Latest Headlines, RheumatologyTweet-
Webinar alert 📯 Join @drjamesgalloway and Dr Chris Edwards on 30 September to learn about efficacy, dosing and retinopathy in #HCQ so you can make confident and appropriate prescribing decisions for #RA and #lupus. For all members across the MDT. ▶️ https://t.co/rP22Ncya4H https://t.co/VI2xQ8yUfl
-
-
Mashup Score: 0Hydroxychloroquine: efficacy, dosing and retinopathy | British Society for Rheumatology - 3 year(s) ago
A webinar to ensure rheumatologists know the llatest information around HCQ efficacy, dosing and retinopathy so they can make confident and appropriate prescribing decisions around this important agent in both rheumatoid arthritis and lupus.
Source: rheumatology.org.ukCategories: Latest Headlines, RheumatologyTweet-
Booked for our #HCQ webinar yet? Join us on 30 September to learn about efficacy, dosing and retinopathy so you can make confident and appropriate prescribing decisions around this important agent in #RA and #lupus. For all members across the MDT. ▶️ https://t.co/rP22NcPKWf https://t.co/o4Y8A6usrG
-
-
Mashup Score: 2Hydroxychloroquine: efficacy, dosing and retinopathy | British Society for Rheumatology - 3 year(s) ago
A webinar to ensure rheumatologists know the llatest information around HCQ efficacy, dosing and retinopathy so they can make confident and appropriate prescribing decisions around this important agent in both rheumatoid arthritis and lupus.
Source: rheumatology.org.ukCategories: Latest Headlines, RheumatologyTweet-
Booked for our #HCQ webinar yet? Join us on 30 September to learn about efficacy, dosing and retinopathy so you can make confident and appropriate prescribing decisions around this important agent in #RA and #lupus. For all members across the MDT. ▶️ https://t.co/rP22Ncya4H https://t.co/Cjl41NgAeV
-
“We found that HCQ dosing management was adequate based on the revised AAO guidelines for #HCQ in patients with #SLE in Korea” https://t.co/z5nAimeSkx